• Je něco špatně v tomto záznamu ?

Poor survival of ABG I hip prosthesis in younger patients

Jiri Gallo, Katerina Langova, Vitezslav Havranek, Ivana Cechova

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10009385

Background: Hydroxyapatite coated (HAC) hip implants have been used in clinical practice for more than twodecades. However, the majority of studies have reported only intermediate term outcomes that are not reliable forpredicting long-term behavior in all implants. The aim of this study was to determine the performance of HAC totalhip arthroplasty in younger patients over a 10-year follow-up period.Methods and Results: This was an observational retrospective study of a 137 consecutive hips with the ABG I prosthesis.Of these, 128 were available for the last investigation. Median duration of follow-up was 10.9 years. The meanage at time of index surgery was 46±6.7 years. Probability of implant survival was estimated using the Kaplan-Meiermethod. The overall 12-year cumulative survival was 0.55 (95% CI, 0.443-0.659). Periprosthetic osteolysis (57 %) wasthe most frequent reason for failure followed by aseptic loosening (28 %). When only aseptic loosening was includedin the analysis, the same fi gures for cup and stem were 0.873 (95% CI, 0.808-0.938) and 0.992 (95% CI, 0.976- 1.0),respectively. Patients with a smaller cup size were those at high risk for revision due to wear-related complications(odds ratio, OR=4.3; 95% CI, 1.734-10.555).Conclusion: This study reports one of the poorest 12-year survivorship data for cementless acetabular componentin the literature. The main reason for premature failure was osteolysis, strongly related to high wear rate of polyethylene.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 25

000      
00000naa 2200000 a 4500
001      
bmc10009385
003      
CZ-PrNML
005      
20111210162324.0
008      
100420s2008 xr e eng||
009      
AR
024    7_
$a 10.5507/bp.2008.027 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Gallo, Jiří $7 xx0019005
245    10
$a Poor survival of ABG I hip prosthesis in younger patients / $c Jiri Gallo, Katerina Langova, Vitezslav Havranek, Ivana Cechova
314    __
$a Department of Orthopedics, Teaching Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc
504    __
$a Lit.: 25
520    9_
$a Background: Hydroxyapatite coated (HAC) hip implants have been used in clinical practice for more than twodecades. However, the majority of studies have reported only intermediate term outcomes that are not reliable forpredicting long-term behavior in all implants. The aim of this study was to determine the performance of HAC totalhip arthroplasty in younger patients over a 10-year follow-up period.Methods and Results: This was an observational retrospective study of a 137 consecutive hips with the ABG I prosthesis.Of these, 128 were available for the last investigation. Median duration of follow-up was 10.9 years. The meanage at time of index surgery was 46±6.7 years. Probability of implant survival was estimated using the Kaplan-Meiermethod. The overall 12-year cumulative survival was 0.55 (95% CI, 0.443-0.659). Periprosthetic osteolysis (57 %) wasthe most frequent reason for failure followed by aseptic loosening (28 %). When only aseptic loosening was includedin the analysis, the same fi gures for cup and stem were 0.873 (95% CI, 0.808-0.938) and 0.992 (95% CI, 0.976- 1.0),respectively. Patients with a smaller cup size were those at high risk for revision due to wear-related complications(odds ratio, OR=4.3; 95% CI, 1.734-10.555).Conclusion: This study reports one of the poorest 12-year survivorship data for cementless acetabular componentin the literature. The main reason for premature failure was osteolysis, strongly related to high wear rate of polyethylene.
650    _2
$a náhrada kyčelního kloubu $x metody $x využití $7 D019644
650    _2
$a hydroxyapatit $x terapeutické užití $7 D017886
650    _2
$a osteolýza $7 D010014
650    _2
$a polyethylen $x terapeutické užití $7 D020959
650    _2
$a statistika jako téma $7 D013223
650    _2
$a analýza přežití $7 D016019
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a financování organizované $7 D005381
700    1_
$a Langová, Kateřina $7 xx0141371
700    1_
$a Havránek, Vítězslav. $7 _AN047673
700    1_
$a Čechová, Ivana $7 xx0093685
773    0_
$w MED00012606 $t Biomedical papers $g Roč. 152, č. 1 (2008), s. 163-168 $x 1213-8118
856    41
$u http://biomed.papers.upol.cz/pdfs/bio/2008/01/27.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 1502 $c 958 $y 8
990    __
$a 20100419115931 $b ABA008
991    __
$a 20100510153214 $b ABA008
999    __
$a ok $b bmc $g 723260 $s 586375
BAS    __
$a 3
BMC    __
$a 2008 $b 152 $c 1 $d 163-168 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x MED00012606
LZP    __
$a 2010-22/dkal

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...